| Product NDC: | 0555-1009 | 
| Proprietary Name: | Clonidine | 
| Non Proprietary Name: | Clonidine | 
| Active Ingredient(s): | .1 mg/24h & nbsp; Clonidine | 
| Administration Route(s): | TRANSDERMAL | 
| Dosage Form(s): | PATCH, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0555-1009 | 
| Labeler Name: | Barr Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA079090 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100825 | 
| Package NDC: | 0555-1009-16 | 
| Package Description: | 4 POUCH in 1 CARTON (0555-1009-16) > 1 PATCH in 1 POUCH > 24 h in 1 PATCH | 
| NDC Code | 0555-1009-16 | 
| Proprietary Name | Clonidine | 
| Package Description | 4 POUCH in 1 CARTON (0555-1009-16) > 1 PATCH in 1 POUCH > 24 h in 1 PATCH | 
| Product NDC | 0555-1009 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Clonidine | 
| Dosage Form Name | PATCH, EXTENDED RELEASE | 
| Route Name | TRANSDERMAL | 
| Start Marketing Date | 20100825 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Barr Laboratories Inc. | 
| Substance Name | CLONIDINE | 
| Strength Number | .1 | 
| Strength Unit | mg/24h | 
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |